RU94004903A - Antitumor and immunomodulating agents and methods of treatment of oncological patients, cutaneous and trophic ulcers - Google Patents

Antitumor and immunomodulating agents and methods of treatment of oncological patients, cutaneous and trophic ulcers

Info

Publication number
RU94004903A
RU94004903A RU94004903/14A RU94004903A RU94004903A RU 94004903 A RU94004903 A RU 94004903A RU 94004903/14 A RU94004903/14 A RU 94004903/14A RU 94004903 A RU94004903 A RU 94004903A RU 94004903 A RU94004903 A RU 94004903A
Authority
RU
Russia
Prior art keywords
treatment
orally
antitumor
cutaneous
befungin
Prior art date
Application number
RU94004903/14A
Other languages
Russian (ru)
Other versions
RU2035182C1 (en
Inventor
Т.В. Воробьева
Original Assignee
Т.В. Воробьева
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Т.В. Воробьева filed Critical Т.В. Воробьева
Priority to RU94004903A priority Critical patent/RU2035182C1/en
Priority to CA002183547A priority patent/CA2183547C/en
Priority to US08/693,041 priority patent/US5889048A/en
Priority to EP94920596A priority patent/EP0804928B1/en
Priority to PCT/RU1994/000128 priority patent/WO1995022336A1/en
Priority to DE69434093T priority patent/DE69434093T2/en
Application granted granted Critical
Publication of RU2035182C1 publication Critical patent/RU2035182C1/en
Publication of RU94004903A publication Critical patent/RU94004903A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

FIELD: medicine, dermatology, oncology. SUBSTANCE: agent has mercuric chloride, semidry, semisweet natural grape wine or whey and 3-4% sugar or honey. Agents were used at definite doses for oncological diseases treatment by orally or external application at different combinations. Also, befungin is used additionally by orally or external application. If patient had preliminary contact with heavy metals then treatment is begun with befungin administration orally. Also, the proposed agents were used for treatment of cutaneous damage, and trophic ulcer both orally and externally. EFFECT: enhanced effectiveness of treatment.

Claims (1)

Изобретение может быть использовано для лечения больных доброкачественными и злокачественными заболеваниями независимо от происхождения и локализации и иммунодефицитами различного происхождения. Сущность изобретения заключается в использовании для лечения противоопухолевых и иммуномодулирующих средств, содержащих в своем составе в качестве активного начала сулему, а также полусухое, полусладкое натуральное виноградное вино или молочную сыворотку с 3 - 4% содержанием сахара или мед. Лекарственные средства используют в определенных количествах для лечения онкологических больных, внутрь и в виде примочек, компрессов, спринцеваний по отдельности или в различных комбинациях. При этом дополнительно применяют наружно и внутрь бефунгин. При предшествующем контакте пациента с тяжелыми металлами лечение начинают с приема буфунгина внутрь. Кроме того, лекарственные средства применяют для лечения кожных заболеваний и трофических язв как внутрь, так и наружно.The invention can be used to treat patients with benign and malignant diseases, regardless of origin and localization and immunodeficiencies of various origin. The essence of the invention is to use for the treatment of antitumor and immunomodulating agents containing as an active principle mercuric chloride, as well as semi-dry, semi-sweet natural grape wine or milk whey with 3-4% sugar or honey. Medicines are used in certain quantities for the treatment of cancer patients, inside and in the form of lotions, compresses, douching individually or in various combinations. In this case, befungin is also used externally and internally. With previous patient contact with heavy metals, treatment begins with bufungin inside. In addition, drugs are used to treat skin diseases and trophic ulcers both inside and out.
RU94004903A 1994-02-18 1994-02-18 Antitumor and immunomodulating agent and method for treatment of oncologic patients and for treatment of dermic disease and trophic ulcers RU2035182C1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
RU94004903A RU2035182C1 (en) 1994-02-18 1994-02-18 Antitumor and immunomodulating agent and method for treatment of oncologic patients and for treatment of dermic disease and trophic ulcers
CA002183547A CA2183547C (en) 1994-02-18 1994-06-15 Compositions for treating defective cell functions
US08/693,041 US5889048A (en) 1994-02-18 1994-06-15 Methods and compositions for treating defective cell functions
EP94920596A EP0804928B1 (en) 1994-02-18 1994-06-15 Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system
PCT/RU1994/000128 WO1995022336A1 (en) 1994-02-18 1994-06-15 Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system
DE69434093T DE69434093T2 (en) 1994-02-18 1994-06-15 SUBSTANCE WITH IMMUNOODULATING EFFECT AND TO REDUCE THE DISFUNCTION OF THE TISSUE CELL CONTROL SYSTEM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94004903A RU2035182C1 (en) 1994-02-18 1994-02-18 Antitumor and immunomodulating agent and method for treatment of oncologic patients and for treatment of dermic disease and trophic ulcers

Publications (2)

Publication Number Publication Date
RU2035182C1 RU2035182C1 (en) 1995-05-20
RU94004903A true RU94004903A (en) 1996-11-20

Family

ID=20152390

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94004903A RU2035182C1 (en) 1994-02-18 1994-02-18 Antitumor and immunomodulating agent and method for treatment of oncologic patients and for treatment of dermic disease and trophic ulcers

Country Status (1)

Country Link
RU (1) RU2035182C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2464974C1 (en) * 2011-10-12 2012-10-27 Учреждение Российской академии наук Институт теоретической и экспериментальной биофизики РАН Means for treatment of malignant ascitic tumours

Also Published As

Publication number Publication date
RU2035182C1 (en) 1995-05-20

Similar Documents

Publication Publication Date Title
CY1105818T1 (en) USES OF ET743 IN THE THERAPEUTIC TREATMENT OF CANCER
ATE241365T1 (en) PREPARATIONS CONTAINING SACCHARIDE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES
RU94038043A (en) Use of the substituted adenine derivatives for multiple sclerosis treatment
DE3582439D1 (en) MEDICINE FOR TREATING HEART DISEASES.
ATE197670T1 (en) PARENTERAL BUSULFAN FOR THE TREATMENT OF MALIGNANT DISEASES
DE58901002D1 (en) AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES.
ATE77230T1 (en) MELATONIN-CONTAINING AGENTS AND THEIR USES.
ATE103804T1 (en) PHARMACEUTICAL PREPARATIONS.
YU13699A (en) Use of 1-hydroxy-2-pyridones for producing pharmaceuticals for the treatment of skin diseases
CZ8595A3 (en) The use of dimerized form of lysozyme for preparing medicaments and pharmaceutical preparations, injection solutions, tampons and antiseptic bandages
RU94004903A (en) Antitumor and immunomodulating agents and methods of treatment of oncological patients, cutaneous and trophic ulcers
DE59108104D1 (en) MEDICINAL PRODUCT CONTAINING CD14
Gravett Aromatherapy treatment for patients with Hickman line infection following high-dose chemotherapy
DE68905076D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN Wounds.
DE69228686D1 (en) MEDICINAL PRODUCT CONTAINING PENCICLOVIR
RU94024337A (en) Antimetastatic agent
RU2189812C2 (en) Method for treating the cold trauma
RU94000695A (en) Agent showing antiallergic action
RU95109228A (en) Method of trophic ulcer treatment
RU94004116A (en) METHOD OF TREATMENT OF PINK UGRAI
RU94022334A (en) Method of treatment and prophylaxis of invasion diseases
RU94021815A (en) Method of treatment of malignant neoplasm
RU94038468A (en) Method of complex etiological treatment of psoriasis with antiviral and antimicrobial preparations
RU92007801A (en) METHOD OF TREATMENT OF PINK UGRAI
RU94026137A (en) Method of neurodermitis treatment

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20070219